These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 17255089

  • 21. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH, Lip GY, Lane DA.
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract] [Full Text] [Related]

  • 22. Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation.
    Marchant BG, Timmis AD.
    Br J Hosp Med; 2009 Mar; 49(3):186-90. PubMed ID: 8439785
    [Abstract] [Full Text] [Related]

  • 23. Atrial fibrillation, thromboembolism and antithrombotic therapy.
    Li-Saw-Hee FL, Lip GY.
    Int J Clin Pract; 1999 Mar; 53(2):110-7. PubMed ID: 10344046
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T.
    Lakartidningen; 1999 Mar; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract] [Full Text] [Related]

  • 27. Additional risk factors in atrial fibrillation patients not receiving warfarin.
    Wensley S, Keir S, Caine S, Mac Mahon M.
    Age Ageing; 1999 Jul; 28(4):355-7. PubMed ID: 10459787
    [Abstract] [Full Text] [Related]

  • 28. [Anticoagulation in aged patients with chronic non-rheumatic atrial fibrillation].
    Rodríguez D, Agustí A.
    Med Clin (Barc); 1999 Mar 27; 112(11):436-7. PubMed ID: 10231778
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Association of warfarin use with CHADS(2) score in 441 patients with nonvalvular atrial fibrillation and no contraindications to warfarin.
    Desai HV, Aronow WS, Gandhi K, Bakerywala S, Laimuanpuii J, Sharma M, Peterson SJ.
    Prev Cardiol; 2010 Mar 27; 13(4):172-4. PubMed ID: 20860640
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Role of antithrombotic therapy in atrial fibrillation.
    Sethi KK, Sudha R.
    Indian Heart J; 1993 Mar 27; 45(6):451-7. PubMed ID: 8070820
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.
    Wellman M, Martin AC.
    J Fam Pract; 1999 Jul 27; 48(7):498. PubMed ID: 10428244
    [No Abstract] [Full Text] [Related]

  • 38. [Diagnosis and treatment of cerebrovascular accidents of cardioembolic origin].
    Ricou FJ, Arroyo JF.
    Praxis (Bern 1994); 1996 Feb 06; 85(6):155-8. PubMed ID: 8701177
    [Abstract] [Full Text] [Related]

  • 39. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.
    Andersen LV, Vestergaard P, Deichgraeber P, Lindholt JS, Mortensen LS, Frost L.
    Heart; 2008 Dec 06; 94(12):1607-13. PubMed ID: 18208828
    [Abstract] [Full Text] [Related]

  • 40. [Clinical study of the month. Prevention of cerebral vascular accidents in patients with atrial fibrillation].
    Scheen AJ.
    Rev Med Liege; 1999 Jun 06; 54(6):561-3. PubMed ID: 10446529
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.